Inactive Instrument

Nutra Pharma Corp. Stock OTC Bulletin Board

Equities

US67060U2087

Biotechnology & Medical Research

Sales 2020 51.9K Sales 2021 97.74K Capitalization 14.65M
Net income 2020 - Net income 2021 -13M EV / Sales 2020 238 x
Net Debt 2020 5.24M Net Debt 2021 8.3M EV / Sales 2021 235 x
P/E ratio 2020
-10.3 x
P/E ratio 2021
-1.1 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Tech/Sci/R&D Officer 62 16-07-26
Corporate Officer/Principal 56 02-11-06
Members of the board TitleAgeSince
Corporate Officer/Principal 56 02-11-06
Director/Board Member 75 04-11-04
Director/Board Member 65 09-07-28
More insiders
Nutra Pharma Corp. is a holding company, which owns intellectual property and operates in the biotechnology industry. The Company conducts drug discovery research and development activities on its own and through its subsidiary, ReceptoPharm, Inc. Its first consumer product, Cobroxin, is an over-the-counter pain reliever designed to treat moderate to severe chronic pain. Its second consumer product, Nyloxin, is an over-the-counter pain reliever that is a stronger version of Cobroxin and is designed to treat severe chronic pain. Pet Pain-Away is an over-the-counter pain reliever designed to treat pain in cats and dogs. Equine Pain-Away is an over-the-counter topical pain reliever designed to treat pain and inflammation in horses. Its Luxury Feet is an over-the-counter pain reliever designed specifically to treat foot pain and inflammation, especially for women who wear high heels and stilettos. The Company also manufactures Cell Defender, ZMUNITY, and Avini Plus Energy, among others.
More about the company